Dr. Aisen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 West Arbor Dr Mc 0949
Ucsd Medical Center
San Diego, CA 92103Phone+1 858-622-2028
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1979 - 1982
Columbia University Vagelos College of Physicians and SurgeonsClass of 1979, MD
Certifications & Licensure
CA State Medical License 2008 - 2025
DC State Medical License 1999 - 2010
VA State Medical License 1999 - 2002- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- 592 citationsThe Amyloid-β Pathway in Alzheimer's Disease.Harald Hampel, John Hardy, Kaj Blennow, Christopher Chen, George Perry
Molecular Psychiatry. 2021-08-30 - 112 citationsAmyloid-β–Associated Clinical Decline Occurs Only in the Presence of Elevated P-tauRahul S. Desikan, Linda K. McEvoy, Wesley K. Thompson, Dominic Holland, James B. Brewer
Archives of Neurology. 2012-06-01 - 3161 citationsHypothetical model of dynamic biomarkers of the Alzheimer's pathological cascadeClifford R. Jack, David S. Knopman, William J. Jagust, Leslie M. Shaw, Paul S. Aisen
The Lancet. Neurology. 2010-01-01
Press Mentions
Alzheimer's Drug from Eisai and Biogen Slows Cognitive Decline, Side-Effects in FocusNovember 30th, 2022- New Alzheimer’s Drug Slows Cognitive DeclineNovember 30th, 2022
- Alzheimer’s Drug Slows Cognitive Decline,November 30th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
